1. Home
  2. TAYD vs CRBP Comparison

TAYD vs CRBP Comparison

Compare TAYD & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$57.03

Market Cap

170.7M

Sector

Industrials

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.27

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
CRBP
Founded
1955
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.7M
184.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
TAYD
CRBP
Price
$57.03
$9.27
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$70.00
$45.50
AVG Volume (30 Days)
39.7K
464.9K
Earning Date
03-31-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
11.24
N/A
EPS
2.87
N/A
Revenue
$46,292,725.00
$4,822,272.00
Revenue This Year
$0.25
N/A
Revenue Next Year
$19.78
$116.00
P/E Ratio
$19.88
N/A
Revenue Growth
3.84
97.62
52 Week Low
$40.50
$7.12
52 Week High
$90.37
$20.56

Technical Indicators

Market Signals
Indicator
TAYD
CRBP
Relative Strength Index (RSI) 52.60 56.91
Support Level $56.80 $7.42
Resistance Level $59.99 $9.57
Average True Range (ATR) 2.74 0.50
MACD 0.16 0.21
Stochastic Oscillator 43.47 86.29

Price Performance

Historical Comparison
TAYD
CRBP

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: